Strain identifier

BacDive ID: 137810

Type strain: No

Species: Actinomyces oris

Strain Designation: 371

Strain history: CIP <- 1982, ATCC, Actinomyces viscosus <- J.M. Slack: strain 371 <- P. Negroni: strain 112, Actinomyces discofoliatus

NCBI tax ID(s): 1656 (species)

« back to strain detail view
For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 8.1 (current version):
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 8.1 (current version)

General

@ref: 38755

BacDive-ID: 137810

keywords: Bacteria, facultative anaerobe, mesophilic, Gram-positive, rod-shaped

description: Actinomyces oris 371 is a facultative anaerobe, mesophilic, Gram-positive bacterium that was isolated from Human, Cervico-facial actinomycosis.

NCBI tax id

  • NCBI tax id: 1656
  • Matching level: species

strain history

  • @ref: 38755
  • history: CIP <- 1982, ATCC, Actinomyces viscosus <- J.M. Slack: strain 371 <- P. Negroni: strain 112, Actinomyces discofoliatus

doi: 10.13145/bacdive137810.20230509.8.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/actinomycetota
  • domain: Bacteria
  • phylum: Actinomycetota
  • class: Actinomycetes
  • order: Actinomycetales
  • family: Actinomycetaceae
  • genus: Actinomyces
  • species: Actinomyces oris
  • full scientific name: Actinomyces oris Henssge et al. 2009

@ref: 38755

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Actinomycetales

family: Actinomycetaceae

genus: Actinomyces

species: Actinomyces oris

strain designation: 371

type strain: no

Morphology

cell morphology

  • @ref: 38755
  • gram stain: positive
  • cell shape: rod-shaped
  • motility: no

colony morphology

  • @ref: 38755

Culture and growth conditions

culture medium

@refnamegrowthcompositionlink
38755MEDIUM 6 - Columbia agar with 10 % horse bloodyesDistilled water make up to (1000.000 ml);Columbia agar (39.000 g);Horseblood (100.000 ml)
38755CIP Medium 6yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=6

culture temp

@refgrowthtypetemperaturerange
38755positivegrowth37mesophilic
38755positivegrowth10-41
38755nogrowth45thermophilic

Physiology and metabolism

oxygen tolerance

  • @ref: 38755
  • oxygen tolerance: facultative anaerobe

halophily

@refsaltgrowthtested relationconcentration
38755NaClpositivegrowth0-2 %
38755NaClnogrowth4 %
38755NaClnogrowth6 %
38755NaClnogrowth8 %
38755NaClnogrowth10 %

metabolite utilization

@refmetaboliteutilization activitykind of utilization testedChebi-ID
68371Potassium 2-ketogluconate-builds acid from
68371gluconate-builds acid from24265
68371L-arabitol-builds acid from18403
68371D-arabitol-builds acid from18333
68371D-fucose-builds acid from28847
68371D-tagatose-builds acid from16443
68371D-lyxose-builds acid from62318
68371turanose-builds acid from32528
68371gentiobiose-builds acid from28066
68371xylitol-builds acid from17151
68371glycogen-builds acid from28087
68371starch-builds acid from28017
68371melezitose-builds acid from6731
68371trehalose-builds acid from27082
68371cellobiose-builds acid from17057
68371salicin-builds acid from17814
68371esculin-builds acid from4853
68371arbutin-builds acid from18305
68371amygdalin-builds acid from27613
68371methyl alpha-D-glucopyranoside-builds acid from320061
68371methyl alpha-D-mannoside-builds acid from43943
68371D-sorbitol-builds acid from17924
68371D-mannitol-builds acid from16899
68371galactitol-builds acid from16813
68371L-rhamnose-builds acid from62345
68371L-sorbose-builds acid from17266
68371methyl beta-D-xylopyranoside-builds acid from74863
68371ribitol-builds acid from15963
68371L-xylose-builds acid from65328
68371D-xylose-builds acid from65327
68371D-ribose-builds acid from16988
68371L-arabinose-builds acid from30849
68371D-arabinose-builds acid from17108
68371erythritol-builds acid from17113
38755citrate-carbon source16947
38755esculin-hydrolysis4853
38755hippurate-hydrolysis606565
38755nitrate-reduction17632
38755nitrite-reduction16301
38755nitrate+respiration17632

antibiotic resistance

  • @ref: 38755
  • metabolite: 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate)
  • is antibiotic: yes
  • is sensitive: yes
  • is resistant: no

metabolite production

  • @ref: 38755
  • Chebi-ID: 35581
  • metabolite: indole
  • production: no

metabolite tests

@refChebi-IDmetabolitevoges-proskauer-testmethylred-test
3875515688acetoin-
3875517234glucose+

enzymes

@refvalueactivityec
38755oxidase-
38755beta-galactosidase+3.2.1.23
38755alcohol dehydrogenase-1.1.1.1
38755gelatinase-
38755amylase+
38755DNase-
38755caseinase-3.4.21.50
38755catalase+1.11.1.6
38755tween esterase-
38755gamma-glutamyltransferase-2.3.2.2
38755lecithinase-
38755lipase-
38755lysine decarboxylase-4.1.1.18
38755ornithine decarboxylase-4.1.1.17
38755phenylalanine ammonia-lyase-4.3.1.24
38755protease-
38755tryptophan deaminase-
38755urease-3.5.1.5
68382alkaline phosphatase+3.1.3.1
68382esterase (C 4)+
68382esterase lipase (C 8)+
68382lipase (C 14)-
68382leucine arylamidase+3.4.11.1
68382valine arylamidase+
68382cystine arylamidase-3.4.11.3
68382trypsin-3.4.21.4
68382alpha-chymotrypsin-3.4.21.1
68382acid phosphatase+3.1.3.2
68382naphthol-AS-BI-phosphohydrolase+
68382alpha-galactosidase+3.2.1.22
68382beta-galactosidase+3.2.1.23
68382beta-glucuronidase-3.2.1.31
68382alpha-glucosidase+3.2.1.20
68382beta-glucosidase+3.2.1.21
68382N-acetyl-beta-glucosaminidase-3.2.1.52
68382alpha-mannosidase-3.2.1.24
68382alpha-fucosidase-3.2.1.51

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
38755-+++-++---++++-++---

API 50CHac

@refGLYERYDARALARARIBDXYLLXYLADOMDXGALGLUFRUMNESBERHADULINOMANSORMDMMDGNAGAMYARBESCSALCELMALLACMELSACTREINUMLZRAFAMDGLYGXLTGENTURLYXTAGDFUCLFUCDARLLARLGNT2KG5KG
38755+/---------+/-+/-+/-+/----+/-----+/------+/-+/-+/-+/--+/--+/---------+/-----+/-

API biotype100

@refGLUFRUGALTREMNESBEMELSACRAFMTEMALLACLTEMbGaMaGaCELGENMbGuESCRIBARAXYLPLERHAFUCMLZDARLLARLXLTDULTAGGLYINOMANMTLTURSORADOHBGLYXERYMDG3MDGSATMUCLTATDTATMTATDMLTLMLTCATETATETTECITGRTGAT2KG5KGTRYNAGGNTPACPATpOBEQATGTEmOBEBATPPATCMTTGEBETPCEABTHINLATCAPCYTHISSUCFUMGREGYTAVTETNTTNGLNITA3OBUAPTGTTPRODALALALASERMNTPROPTYR2KT
38755---------------------------------------------------------------------------------------------------

Isolation, sampling and environmental information

isolation

  • @ref: 38755
  • sample type: Human, Cervico-facial actinomycosis

Safety information

risk assessment

  • @ref: 38755
  • biosafety level: 2
  • biosafety level comment: Risk group (French classification)

External links

@ref: 38755

culture collection no.: CIP 100655, ATCC 19246

straininfo link

  • @ref: 94629
  • straininfo: 92856

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Pathogenicity344340Quantitative fluorescent immunoassay of antibodies to, and surface antigens of, Actinomyces viscosus.Gillis TP, Thompson JJJ Clin Microbiol10.1128/jcm.7.2.202-208.19781978Actinomyces/*immunology, Antibodies, Bacterial/*analysis, Antigens, Bacterial/*analysis, Cell Membrane/immunology, Dental Plaque/microbiology, Fluorescent Antibody Technique/*methods/standards, Humans
Pathogenicity977126Blastogenic response of human lymphocytes to oral bacterial antigens: characterization of bacterial sonicates.Reed MJ, Patters MR, Mashimo PA, Genco RJ, Levine RJInfect Immun10.1128/iai.14.5.1202-1212.19761976Actinomyces/immunology, Antigens, Bacterial/*analysis, Cell-Free System, Humans, Immunity, Cellular, Immunoelectrophoresis, *Lymphocyte Activation, Mouth/*microbiology, *Sonication, Time Factors, *Ultrasonics, Veillonella/immunologyEnzymology
Metabolism2358461Characterization of the binding of Actinomyces naeslundii (ATCC 12104) and Actinomyces viscosus (ATCC 19246) to glycosphingolipids, using a solid-phase overlay approach.Stromberg N, Karlsson KAJ Biol ChemS0021-9258(19)38584-91990Actinomyces/*metabolism, *Antigens, CD, Bacterial Adhesion, Carbohydrate Sequence, Chromatography, Thin Layer, Epithelium/analysis, Erythrocytes/analysis, Fatty Acids, Gangliosides, Glycosphingolipids/*metabolism, Humans, Hydroxylation, Iodine Radioisotopes, *Lactosylceramides, Molecular Sequence Data, Mouth/analysis, Structure-Activity Relationship, Sulfur RadioisotopesPathogenicity
3655719Surface localization of sialic acid on Actinomyces viscosus.Jones AH, Lee CC, Moncla BJ, Robinovitch MR, Birdsell DCJ Gen Microbiol10.1099/00221287-132-12-33811986Actinomyces/*analysis, Agglutination, Arthropod Proteins, Chromatography, Paper, Lectins, Microscopy, Fluorescence, Sialic Acids/*analysis/biosynthesis, Spectrophotometry
Enzymology3679542Purification and characterization of levanase from Actinomyces viscosus ATCC 19246.Igarashi T, Takahashi M, Yamamoto A, Etoh Y, Takamori KInfect Immun10.1128/iai.55.12.3001-3005.19871987Actinomyces/*enzymology, *Bacterial Proteins, Glycoside Hydrolases/*isolation & purification, Hydrogen-Ion Concentration, Metals/pharmacology, Substrate Specificity, TemperaturePhylogeny
Metabolism6481336A possible mechanism for the cellular coaggregation between Actinomyces viscosus ATCC 19246 and Streptococcus sanguis ATCC 10557.Sato S, Koga T, Inoue MJ Gen Microbiol10.1099/00221287-130-6-13511984Actinomyces/drug effects/*metabolism, Calcium/pharmacology, Carbohydrates/pharmacology, Cell Wall/metabolism, Hot Temperature, Lectins/pharmacology, Streptococcus sanguis/drug effects/*metabolism, Trypsin/pharmacologyPathogenicity
Enzymology7154407Novel antigens of oral Actinomyces species prepared from a cell wall enzyme lysate.Hamada S, Okahashi N, Kimura S, Imanishi H, Koga T, Kawata S, Michalek SM, McGhee JRJpn J Med Sci Biol10.7883/yoken1952.35.1711982Actinomyces/*immunology, Animals, Antigens, Bacterial/analysis/*isolation & purification, Cell Wall/immunology, Chromatography, Immune Sera/immunology, Muramidase/pharmacology, Rabbits, SolubilityPhylogeny
Pathogenicity7492899Antibacterial action of dental cements: an in vitro study.Morrier JJ, Rocca JP, Barsotti OBull Group Int Rech Sci Stomatol Odontol1995Actinomyces/*drug effects/growth & development, Analysis of Variance, Anti-Bacterial Agents/*pharmacology, Dental Cements/*pharmacology, Humans, Microbial Sensitivity Tests, Saliva/microbiology, Streptococcus mutans/*drug effects/growth & development, Streptococcus sanguis/*drug effects/growth & development
Pathogenicity8510131Induction of inflammatory cytokines by a soluble moiety prepared from an enzyme lysate of Actinomyces viscosus cell walls.Takada H, Kimura S, Hamada SJ Med Microbiol10.1099/00222615-38-6-3951993Actinomyces viscosus/*chemistry, Animals, Antigens, Bacterial/*pharmacology, Cell Wall/*chemistry, Cells, Cultured, Cytokines/*biosynthesis, Female, Inflammation/*immunology, Interleukin-6/biosynthesis, Macrophages/drug effects/metabolism, Male, Mice, Mice, Inbred C3H, Tumor Necrosis Factor-alpha/biosynthesisEnzymology
9184801Inhibition of a Porphyromonas gingivalis colonizing factor between Actinomyces viscosus ATCC 19246 by monoclonal antibodies against recombinant 40-kDa outer-membrane protein.Saito S, Hiratsuka K, Hayakawa M, Takiguchi H, Abiko YGen Pharmacol10.1016/s0306-3623(96)00366-71997Actinomyces viscosus/immunology/*physiology, Animals, Antibodies, Monoclonal/*immunology, Bacterial Adhesion/immunology/physiology, Bacterial Outer Membrane Proteins/*immunology, Enzyme-Linked Immunosorbent Assay, Female, Mice, Mice, Inbred BALB C, Porphyromonas gingivalis/immunology/*physiology, Radioimmunoassay, Recombinant Proteins/immunology
Metabolism10225854Strains of Actinomyces naeslundii and Actinomyces viscosus exhibit structurally variant fimbrial subunit proteins and bind to different peptide motifs in salivary proteins.Li T, Johansson I, Hay DI, Stromberg NInfect Immun10.1128/IAI.67.5.2053-2059.19991999Actinomyces/*chemistry/genetics/pathogenicity, Amino Acid Sequence, Animals, Bacterial Proteins/*chemistry/genetics/metabolism, Base Sequence, Binding Sites, Cricetinae, DNA Primers/genetics, Fimbriae, Bacterial/chemistry, Genes, Bacterial, Humans, Molecular Sequence Data, Mouth/microbiology, Protein Binding, Rats, Salivary Proteins and Peptides/*metabolism, Sequence Homology, Amino Acid, Species SpecificityPathogenicity
Pathogenicity11456067Comparison of corrosion behaviour in presence of oral bacteria.Laurent F, Grosgogeat B, Reclaru L, Dalard F, Lissac MBiomaterials10.1016/s0142-9612(00)00416-62001Actinomyces/physiology, Corrosion, *Dental Alloys, Electric Impedance, Electrochemistry, Humans, In Vitro Techniques, Materials Testing, Microscopy, Electron, Scanning, Mouth/*microbiology, Saliva/microbiology, Surface Properties
Pathogenicity11769659[Experimental study of bacteriostatic activity of Chinese herbal medicines on primary cariogenic bacteria in vitro].Wang S, Fan M, Bian ZZhonghua Kou Qiang Yi Xue Za Zhi2001Cariogenic Agents/*pharmacology, Drugs, Chinese Herbal/*pharmacology, Humans, Microbial Sensitivity Tests, Streptococcus mutans/*drug effects
Pathogenicity12539656[The effects of tea polyphenols on the adherence of cariogenic bacterium to the salivary acquired pellicle in vitro].Xiao Y, Liu T, Zhan L, Zhou XHua Xi Kou Qiang Yi Xue Za Zhi2000Actinomyces viscosus/*drug effects, Bacterial Adhesion/*drug effects, Dental Caries/*microbiology, Dental Pellicle, Dose-Response Relationship, Drug, Hydroxyapatites, In Vitro Techniques, Phenols/*pharmacology, Saliva, Streptococcus mutans/*drug effects, Tea/*chemistry
Pathogenicity12539657[The effects of tea polyphenols on the adherence of cariogenic bacterium to the collagen in vitro].Xiao Y, Liu T, Zhan L, Zhou XHua Xi Kou Qiang Yi Xue Za Zhi2000Actinomyces viscosus/*drug effects, Bacterial Adhesion/*drug effects, Collagen, Dental Caries/*microbiology, Dental Pellicle, Dose-Response Relationship, Drug, Hydroxyapatites, In Vitro Techniques, Phenols/*pharmacology, Streptococcus mutans/*drug effects, Tea/*chemistry
Pathogenicity12575187[Effect of para-aminobenzoic acid on the growth of Actinomyces viscosus].Guo B, Zhou X, Xiao X, Li L, Zhu ZHua Xi Yi Ke Da Xue Xue Bao2002Actinomyces viscosus/*drug effects/*growth & development, Dose-Response Relationship, Drug, Nitriles/*pharmacology, Stem Cells/drug effects
Biotechnology12575200[The in vitro study of the effects of 11 kinds of traditional Chinese medicine on the growth and acid production of Actinomyces viscosus].Xiao Y, Liu T, Huang Z, Zhou X, Li GHua Xi Yi Ke Da Xue Xue Bao2002Acids/analysis, Actinomyces viscosus/*drug effects/metabolism, Cariostatic Agents/*pharmacology, Drugs, Chinese Herbal/*pharmacology, *Flavonoids, Phenols/pharmacology, Polymers/pharmacology, PolyphenolsPathogenicity
14966611[Comparison of the antibacterial activity on oral pathogens among six types of nano-silver base inorganic antibacterial agents].She WJ, Zhang FQShanghai Kou Qiang Yi Xue14222003Anti-Bacterial Agents/*pharmacology, Mouth/*microbiology, Silver Compounds/*pharmacology
14983338[The in vitro study on Polistes mandarinus' effects on cariogenic bacteria].Huang ZW, Xiao Y, Liu TJ, Zhou XD, Li JY, Zhan LShanghai Kou Qiang Yi Xue10942002
15804032[The effect of galla chinensis on the growth of cariogenic bacteria in vitro].Xie Q, Li JY, Zuo YL, Zhou XDHua Xi Kou Qiang Yi Xue Za Zhi2005Actinomyces viscosus, Anti-Bacterial Agents, Bacteria, Dental Caries, Drugs, Chinese Herbal, In Vitro Techniques, *Streptococcus mutans, Streptococcus sanguis
Pathogenicity15931873[An in vitro study on effect of Nidus vespae extract on the acid production of three strains of oral bacteria].Zuo YL, Li JY, Xie Q, Zhou XDSichuan Da Xue Xue Bao Yi Xue Ban2005Acids, Actinomyces viscosus/*drug effects, Animals, Bees, Dental Caries/microbiology, Dental Plaque/microbiology, Drugs, Chinese Herbal/*pharmacology, Humans, Materia Medica/pharmacology, Mouth/*microbiology, Streptococcus mutans/*drug effects, Streptococcus sanguis/*drug effectsBiotechnology
Pathogenicity22561467Lipoproteins of Actinomyces viscosus induce inflammatory responses through TLR2 in human gingival epithelial cells and macrophages.Shimada E, Kataoka H, Miyazawa Y, Yamamoto M, Igarashi TMicrobes Infect10.1016/j.micinf.2012.04.0152012Actinomyces viscosus/chemistry/*immunology, Actinomycosis/immunology/microbiology, Analysis of Variance, Bacterial Proteins/immunology, Cytokines/immunology, Epithelial Cells/cytology/immunology, Gingiva/cytology/*immunology, Gingival Diseases/immunology/microbiology, HEK293 Cells, Host-Pathogen Interactions, Humans, Inflammation/immunology, Lipoproteins/*immunology, Macrophages/cytology/immunology, Toll-Like Receptor 2/*immunology
Pathogenicity23107192Incorporation of antimicrobial agents can be used to enhance the antibacterial effect of endodontic sealers.Gjorgievska E, Apostolska S, Dimkov A, Nicholson JW, Kaftandzieva ADent Mater10.1016/j.dental.2012.10.0022012Actinomyces viscosus/*drug effects, Analysis of Variance, Anti-Bacterial Agents/*pharmacology, Benzalkonium Compounds/*pharmacology, Cetylpyridinium/*pharmacology, Lactobacillus casei/*drug effects, Root Canal Filling Materials/*pharmacology, Streptococcus mutans/*drug effects

Reference

@idauthorstitledoi/urlcatalogue
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ10.1099/ijsem.0.004332
38755Curators of the CIPhttps://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%20100655Collection of Institut Pasteur (CIP 100655)
68371Automatically annotated from API 50CH acid
68382Automatically annotated from API zym
94629Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.StrainInfo: A central database for resolving microbial strain identifiers10.60712/SI-ID92856.1